The convergence of AI-driven engineering biology and emerging technologies advancing globally networked autonomous biofoundries

Since the emergence of synthetic biology, biofoundries have developed as enabling infrastructures that scale engineering biology globally. Landmark initiatives, such as Genome Project-Write, JCVI-syn3.0, Sc2.0, SynMoss and the Synthetic Human Genome Project, have significantly advanced the feasibility of constructing chromosome-sized DNA and revealed key principles of genome function and design. Nevertheless, the intrinsic complexity of cellular systems and the resource-intensive nature of experimental design-build-test-learn cycles continue to constrain innovation. Recent advances in artificial intelligence (AI), whole-cell modelling and digital twinning are now creating opportunities for self-improving, AI-driven biofoundries that seamlessly integrate in silico design and validation with miniaturised and automated in vitro testing. This review surveys the technologies shaping AI-driven synthetic biology, highlighting their convergence with automation, digitisation and miniaturisation to enable fully autonomous biofoundries that unify computational design, automated fabrication and data-driven learning within a single adaptive framework.

Authors

Institutions

Publication Details

Journal
Current Opinion in Biotechnology
Published
2026-05-01
DOI
https://doi.org/10.1016/j.copbio.2026.103503
Primary Topic
Gene Regulatory Network Analysis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The convergence of AI-driven engineering biology and emerging technologies advancing globally networked autonomous biofoundries

Ryan R. Cochrane, Leandro Vieira dos Santos, Yizhi Cai
Current Opinion in Biotechnology
Gene Regulatory Network Analysis
article

The convergence of AI-driven engineering biology and emerging technologies advancing globally networked autonomous biofoundries

Ryan R. Cochrane, Leandro Vieira dos Santos, Yizhi Cai
article en

Abstract

Since the emergence of synthetic biology, biofoundries have developed as enabling infrastructures that scale engineering biology globally. Landmark initiatives, such as Genome Project-Write, JCVI-syn3.0, Sc2.0, SynMoss and the Synthetic Human Genome Project, have significantly advanced the feasibility of constructing chromosome-sized DNA and revealed key principles of genome function and design. Nevertheless, the intrinsic complexity of cellular systems and the resource-intensive nature of experimental design-build-test-learn cycles continue to constrain innovation. Recent advances in artificial intelligence (AI), whole-cell modelling and digital twinning are now creating opportunities for self-improving, AI-driven biofoundries that seamlessly integrate in silico design and validation with miniaturised and automated in vitro testing. This review surveys the technologies shaping AI-driven synthetic biology, highlighting their convergence with automation, digitisation and miniaturisation to enable fully autonomous biofoundries that unify computational design, automated fabrication and data-driven learning within a single adaptive framework.

Current Opinion in BiotechnologyVol. 99
University of Manchester (GB)
University of Manchester, Engineering and Physical Sciences Research Council, Biotechnology and Biological Sciences Research Council, European Research Council
Industry, innovation and infrastructure
Openalex Percentile: Top 11%
Gene Regulatory Network Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The convergence of AI-driven engineering biology and emerging technologies advancing globally networked autonomous biofoundries — Ryan R. Cochrane, Leandro Vieira dos Santos, et al. · Current Opinion in Biotechnology (2026) | TGRS Research Map | TGRS